• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIAGNOSTICS SCARBOROUGH, INC. BINAXNOW COVID-19 AG SELF TEST 2CT; CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIAGNOSTICS SCARBOROUGH, INC. BINAXNOW COVID-19 AG SELF TEST 2CT; CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM. Back to Search Results
Catalog Number 195-160
Device Problem Non Reproducible Results (4029)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/19/2023
Event Type  malfunction  
Manufacturer Narrative
D4-lot:224390; d4-expiration:8/12/2024; d4-udi:(b)(4).The remainder of the investigation remains in progress.A supplemental report will be provided after completion.H3 other text : single use; device discarded.
 
Event Description
The consumer reported conflicting results with the binaxnow covid-19 antigen self-test kit performed on (b)(6) 2023 on a nasal kitted swab.On (b)(6) 2023, the first test taken (lot number: unknown) generated a negative result, and the second test (lot number:224390), performed on the same day, generated a positive result.Repeat testing was performed on (b)(6) 2023 which generated a positive result.The consumer confirmed there was no harm due to the test results.Additionally, the consumer confirmed there was no delay or impact in treatment.
 
Manufacturer Narrative
Second test lot information: d4-lot:224390 d4-expiration:8/12/2024 d4-udi:(b)(4).Investigation results: customer was unable to provide the lot number for the first test.The information to enable further investigation, such as the kit's lot number, was not provided and an investigation was not able to be performed.Notwithstanding, complaints against these trend codes are monitored to identify and track any out-of-trend/unexpected performance at the lot and product family level.Testing was performed in triplicate at abbott diagnostics scarborough, inc.On retained kit lot 224390 with internal positive quality control samples and negative quality control swabs.All test results were valid and performed as expected.Additionally, the manufacturing records and quality control release testing was reviewed for kit part number 195-160/ lot 224390 and device part number 195-430h/ lot 220619.The lot met the required release specifications.A review of the complaints reported as false negative patient results (confirmed and unconfirmed, conflicting results) related to kit lot 224390 showed that the complaint rate is 0.(b)(4).A review of the complaints reported as false positive patient results (confirmed and unconfirmed, conflicting results) related to kit lot 224390 showed that the complaint rate is (b)(4).Abbott diagnostics scarborough, inc.Was unable to determine the exact root cause of the reported issue.
 
Event Description
The consumer reported conflicting results with the binaxnow covid-19 antigen self-test kit performed on 19oct2023 on a nasal kitted swab.On 19oct2023, the first test taken (lot number: unknown) generated a negative result, and the second test (lot number:224390), performed on the same day, generated a positive result.Repeat testing was performed on 20oct2023 which generated a positive result.The consumer confirmed there was no harm due to the test results.Additionally, the consumer confirmed there was no delay or impact in treatment.
 
Event Description
The consumer reported conflicting results with the binaxnow covid-19 antigen self-test kit performed on (b)(6) 2023 on a nasal kitted swab.On (b)(6) 2023, the first test taken (lot number: unknown) generated a negative result, and the second test (lot number:224390), performed on the same day, generated a positive result.Repeat testing was performed on (b)(6) 2023 which generated a positive result.The consumer confirmed there was no harm due to the test results.Additionally, the consumer confirmed there was no delay or impact in treatment.
 
Manufacturer Narrative
Second test lot information: d4-lot: 224390, d4-expiration: 8/12/2024, and d4-udi: (b)(4).The remainder of the investigation remains in progress.A supplemental report will be provided after completion.B5-corrected date of occurrence month from september to october.H3 other text : single use; device discarded.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BINAXNOW COVID-19 AG SELF TEST 2CT
Type of Device
CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.
Manufacturer (Section D)
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
10 southgate road
scarborough ME 04074
Manufacturer Contact
rachel blackwell
10 southgate road
scarborough, ME 04074
6613888803
MDR Report Key18051825
MDR Text Key327296220
Report Number1221359-2023-01608
Device Sequence Number1
Product Code QKP
UDI-Device Identifier00811877011408
UDI-Public00811877011408
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
EUA210264
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup
Report Date 11/21/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Catalogue Number195-160
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 10/20/2023
Initial Date FDA Received11/01/2023
Supplement Dates Manufacturer Received11/10/2023
11/17/2023
Supplement Dates FDA Received11/16/2023
11/21/2023
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age52 YR
Patient SexFemale
Patient Weight53 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-